Related references
Note: Only part of the references are listed.Progress with, and prospects for, metal complexes in cell imaging
Michael P. Coogan et al.
CHEMICAL COMMUNICATIONS (2014)
Bioactive Luminescent Transition-Metal Complexes for Biomedical Applications
Dik-Lung Ma et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent
Swagata Banerjee et al.
CHEMICAL COMMUNICATIONS (2013)
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Wukun Liu et al.
CHEMICAL SOCIETY REVIEWS (2013)
Recent advances in the development of 1,8-naphthalimide based DNA targeting binders, anticancer and fluorescent cellular imaging agents
Swagata Banerjee et al.
CHEMICAL SOCIETY REVIEWS (2013)
N-Heterocyclic carbene metal complexes in medicinal chemistry
Luciano Oehninger et al.
DALTON TRANSACTIONS (2013)
Oxo-heterocyclic fused naphthalimides as antitumor agents: Synthesis and biological evaluation
Shaoying Tan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design, Synthesis and pH Sensing Properties of Novel PAMAM Light-Harvesting Dendrons Based on Rhodamine 6G and 1,8-naphthalimide
Nikolai I. Georgiev et al.
JOURNAL OF FLUORESCENCE (2013)
Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights
Anna Citta et al.
METALLOMICS (2013)
The effect of the 4-amino functionality on the photophysical and DNA binding properties of alkyl-pyridinium derived 1,8-naphthalimides
Swagata Banerjee et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Novel Ruthenium(II) and Gold(I) NHC Complexes: Synthesis, Characterization, and Evaluation of Their Anticancer Properties
Frauke Hackenberg et al.
ORGANOMETALLICS (2013)
Small molecule inhibitors of mammalian thioredoxin reductase
Wenqing Cai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Gold(I)-NHC complexes of antitumoral diarylimidazoles: Structures, cellular uptake routes and anticancer activities
Leonard Kaps et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Design, synthesis and sensor activity of a highly photostable blue emitting 1,8-naphthalimide
Nikolai I. Georgiev et al.
JOURNAL OF LUMINESCENCE (2012)
Advances in metal-carbene complexes as potent anti-cancer agents
Arnaud Gautier et al.
METALLOMICS (2012)
Naphthalimide-Tagged Ruthenium-Arene Anticancer Complexes: Combining Coordination with Intercalation
Kelly J. Kilpin et al.
ORGANOMETALLICS (2012)
A spontaneous gold(I)-azide alkyne cycloaddition reaction yields gold-peptide bioconjugates which overcome cisplatin resistance in a p53-mutant cancer cell line
S. David Koester et al.
CHEMICAL SCIENCE (2012)
Real-Time Monitoring of Cisplatin-Induced Cell Death
Hamed Alborzinia et al.
PLOS ONE (2011)
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays
Chiara Gabbiani et al.
MEDCHEMCOMM (2011)
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
Arne Holmgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Colorimetric and fluorescent anion sensors: an overview of recent developments in the use of 1,8-naphthalimide-based chemosensors
Rebecca M. Duke et al.
CHEMICAL SOCIETY REVIEWS (2010)
Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A New Class of Naphthalimide-Based Antitumor Agents That Inhibit Topoisomerase II and Induce Lysosomal Membrane Permeabilization and Apoptosis
Zhuo Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Comparative studies on the cytotoxicity, cellular and nuclear uptake of a series of chloro gold(I) phosphine complexes
Heike Scheffler et al.
POLYHEDRON (2010)
In Vitro and Murine Efficacy and Toxicity Studies of Nebulized SCC1, a Methylated Caffeine-Silver(I) Complex, for Treatment of Pulmonary Infections
Carolyn L. Cannon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Alberto Bindoli et al.
COORDINATION CHEMISTRY REVIEWS (2009)
Overview of Naphthalimide Analogs as Anticancer Agents
Min Lv et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs
Christoph P. Bagowski et al.
DALTON TRANSACTIONS (2009)
Photocytotoxic 3d-Metal Scorpionates with a 1,8-Naphthalimide Chromophore Showing Photoinduced DNA and Protein Cleavage Activity
Sovan Roy et al.
INORGANIC CHEMISTRY (2009)
A Gold(I) Phosphine Complex Containing a Naphthalimide Ligand Functions as a TrxR Inhibiting Antiproliferative Agent and Angiogenesis Inhibitor
Ingo Ott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells
Ingo Ott et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
The synthesis of ruthenium and rhodium complexes with functionalized N-heterocyclic carbenes and their use in solid phase peptide synthesis
Jessica Lemke et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2008)
Thioredoxin signaling as a target for cancer therapy
Garth Powis et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
On the potential of thioredoxin reductase inhibitors for cancer therapy
Sabine Urig et al.
SEMINARS IN CANCER BIOLOGY (2006)
Synthesis from caffeine of a mixed N-heterocyclic carbene-silver acetate complex active against resistant respiratory pathogens
Aysegul Kascatan-Nebioglu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity
Murray V. Baker et al.
DALTON TRANSACTIONS (2006)
Protein crosslinking by 1,8-naphthalimides: influence of the 4-substituent
RJ Woods et al.
ARKIVOC (2003)
Multiparametric microsensor chips for screening applications
R Ehret et al.
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY (2001)
Thioredoxin reductase as a pathophysiological factor and drug target
K Becker et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
